This compound is a structural analog of sitagliptin, specifically an enamine impurity that serves as a reference standard in pharmaceutical quality control. It is identified by the systematic chemical description this compound.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 767340-03-4
7-Methoxy-2-methyl-1,3(2H,4H)-isoquinolinedione
pharmaceutical intermediate
Chlorodimethylphenylsilane
pharmaceutical intermediate
5-amino-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide
pharmaceutical intermediate
Carboxymethyl acemetacin
pharmaceutical intermediate
(Z)-3-amino-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)but-2-en-1-one
RLSFDUAUKXKPCZ-UITAMQMPSA-N
C1CN2C(=NN=C2C(F)(F)F)CN1C(=O)/C=C(/CC3=CC(=C(C=C3F)F)F)\N